Female superiority.
The median expected survival in Swedish women is 10% longer than that in men and still increasing, while that in men stopped going up 10 years ago. Women have a better prognosis than men in chronic myelocytic leukemia, in acute lymphatic and myeloid leukemias, in multiple myeloma and in malignant lymphoma given immunotherapy. There are some early indications that women may be more resistant than men to malignant transformation induced by radiation or smoking.
D002471:Cell Transformation, Neoplastic; D005260:Female; D006801:Humans; D008017:Life Expectancy; D008297:Male; D009369:Neoplasms / Q000401:mortality; D011956:Receptors, Cell Surface; D012737:Sex Factors; D013548:Sweden
D011956:Receptors, Cell Surface